Galectin Therapeutics Announces Positive Preliminary Results from Phase 1b Clinical Trial of GR-MD-02 and KEYTRUDA
Pharmaceutical Investing Galectin Therapeutics Receives Patent for GR-MD-02 Patent for Method and Treatment of Pulmonary Fibrosis
Pharmaceutical Investing Galectin Therapeutics Reports 2017 Financial Results and Provides Business Update
Skyharbour Partner Company Terra Clean Energy Completes Winter Drill Program with Encouraging Results and Prepares a Significant Summer Drill Program at the South Falcon East Uranium Project
Riverside Resources Moves Ahead on Plan to Spin Out Blue Jay to Shareholders After Approval at the Annual and Special Meeting
1911 Gold Intersects up to 14.97 g/t Gold over 2.70 m including 71.60 g/t Au over 0.50 m on SAM Southeast Zone at True North
